LUTADENOVEC AUTOGENE VIRAL GENOME
UNII H2D7GJ5FAW

Substance Identification & Data

This profile provides standardized clinical and technical data for Lutadenovec Autogene Viral Genome, uniquely identified by the FDA Unique Ingredient Identifier (UNII) H2D7GJ5FAW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
H2D7GJ5FAW
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LUTADENOVEC AUTOGENE VIRAL GENOME
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lutadenovec Autogene Viral Genome. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

GRT-C901 VIRAL GENOME
GRT-C901 VIRAL GENOME (DNA (CHIMPANZEE ADENOVIRUS 68-DERIVED CONSTRUCT GRT-C901 VIRAL PROTEIN GENE E1 DELETION PLUS VIRAL PROTEIN GENE E3 DELETION PLUS VIRAL PROTEIN GENE E4 DELETION-CONTAINING PLUS CYTOMEGALOVIRUS PROMOTER PLUS TRANSCRIPTION FACTOR TETR (TETRACYLINE REPRESSOR)-RESPONSE ELEMENT CMT PLUS TUMOR-SPECIFIC NEOANTIGEN PROTOTYPE CASSETTE-EXPRESSING))
LUTADENOVEC AUTOGENE VIRAL GENOME

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record